Darin Busby
Jackson, MSNPI 1831651405
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.5%), grants and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medtronic at 39.2% of the total. 2025 is the largest year on record at $2,645, more than ten times the $124 reported in 2021.
Across 81 payments — averaging $63.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$453
- AstraZeneca$450
- Abiomed$404
- Boehringer Ingelheim$304
- Pfizer$162
- plus $1K from 17 others
What the payments were for
- Grants$2,00039%
- Food & beverage$3,00758%
- Education$1363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 2 | $2,018 |
| Boston Scientific | 6 | $453 |
| AstraZeneca | 9 | $450 |
| Abiomed | 5 | $404 |
| Boehringer Ingelheim | 10 | $304 |
| Pfizer | 10 | $162 |
| Abbott | 2 | $160 |
| Penumbra, Inc. | 1 | $143 |
| E.r. Squibb & Sons, L.L.C. | 8 | $131 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $124 |
| Irhythm Technologies, Inc. | 3 | $122 |
| Philips North America LLC | 1 | $113 |
| Novartis | 6 | $107 |
| Amgen | 2 | $104 |
| Shockwave Medical, Inc | 1 | $92 |
| Merck | 4 | $74 |
| Novo Nordisk | 2 | $37 |
| United Therapeutics Corporation | 1 | $35 |
| Johnson & Johnson | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 2 | $27 |
| Bridgebio Pharma, Inc. | 1 | $20 |
| Livanova USA, Inc. | 1 | $15 |
| Edwards Lifesciences | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$237
- Farapulse$196
- Indigo System$143
- ENSITE$136
- JARDIANCE$125
- BRILINTA$124
- XIFAXAN$124
- (9520) IGT Devices Undivided$113
- WATCHMAN Access System$113
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 25 | $199 |
| Atorvastatin Calcium | 12 | $168 |
| Irbesartan | 15 | $130 |
| Metoprolol Succinate | 11 | $100 |
| Amlodipine Besylate | 20 | $98 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 18 | $80 |
| Pantoprazole Sodium | 13 | $78 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $64 |
| Glimepiride | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.